{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:30:23Z","timestamp":1791275423112,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.intimp.2015.08.037","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T03:08:32Z","timestamp":1442027312000},"page":"818-823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Epigallocatechin-3-gallate attenuates bone cancer pain involving decreasing spinal Tumor Necrosis Factor-\u03b1 expression in a mouse model"],"prefix":"10.1016","volume":"29","author":[{"given":"Qingsong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2015.08.037_bb0005","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.intimp.2015.08.037_bb0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.intimp.2015.08.037_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3959(96)03267-8","article-title":"Malignant bone pain: pathophysiology and treatment","volume":"69","author":"Mercadante","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.intimp.2015.08.037_bb0020","doi-asserted-by":"crossref","first-page":"10886","DOI":"10.1523\/JNEUROSCI.19-24-10886.1999","article-title":"Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain","volume":"19","author":"Schwei","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2015.08.037_bb0025","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2015.08.037_bb0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0306-4522(02)00165-3","article-title":"Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur","volume":"113","author":"Mach","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2015.08.037_bb0035","doi-asserted-by":"crossref","first-page":"9355","DOI":"10.1523\/JNEUROSCI.21-23-09355.2001","article-title":"Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain","volume":"21","author":"Wacnik","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2015.08.037_bb0040","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0306-4522(00)00110-X","article-title":"Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons","volume":"98","author":"Honore","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2015.08.037_bb0045","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","article-title":"Regulation of cancer cell migration and bone metastasis by RANKL","volume":"440","author":"Jones","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2015.08.037_bb0050","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2015.08.037_bb0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.191.2.275","article-title":"Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL\u2013RANK interaction","volume":"191","author":"Kobayashi","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2015.08.037_bb0060","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1128\/MCB.17.7.4015","article-title":"Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis","volume":"17","author":"Yoshida","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.intimp.2015.08.037_bb0065","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/(SICI)1097-0215(20000115)85:2%3C182::AID-IJC6%3E3.0.CO;2-M","article-title":"Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha","volume":"85","author":"Torisu","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2015.08.037_bb0070","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuroscience.2004.12.035","article-title":"Nociceptive characteristics of tumor necrosis factor-alpha in naive and tumor-bearing mice","volume":"132","author":"Wacnik","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2015.08.037_bb0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrc747","article-title":"Molecular mechanisms of cancer pain","volume":"2","author":"Mantyh","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2015.08.037_bb0080","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.neuroscience.2010.04.022","article-title":"Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain","volume":"169","author":"Geis","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2015.08.037_bb0085","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10408690390826464","article-title":"Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions","volume":"43","author":"Higdon","year":"2003","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.intimp.2015.08.037_bb0090","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0027-5107(01)00183-X","article-title":"Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation","volume":"480\u2013481","author":"Surh","year":"2001","journal-title":"Mutat. Res."},{"key":"10.1016\/j.intimp.2015.08.037_bb0095","doi-asserted-by":"crossref","first-page":"e0123122","DOI":"10.1371\/journal.pone.0123122","article-title":"Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in mice","volume":"10","author":"Xifro","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2015.08.037_bb0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2011.11.037","article-title":"Effects of intrathecal epigallocatechin gallate, an inhibitor of Toll-like receptor 4, on chronic neuropathic pain in rats","volume":"676","author":"Kuang","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2015.08.037_bb0105","first-page":"1243","article-title":"Chronic oral epigallocatechin-gallate alleviates streptozotocin-induced diabetic neuropathic hyperalgesia in rat: involvement of oxidative stress","volume":"11","author":"Baluchnejadmojarad","year":"2012","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.intimp.2015.08.037_bb0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.brainresbull.2011.06.007","article-title":"Epigallocatechin gallate ameliorates behavioral and biochemical deficits in rat model of load-induced chronic fatigue syndrome","volume":"86","author":"Sachdeva","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.intimp.2015.08.037_bb0115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1744-8069-6-64","article-title":"Intraperitoneal injection of thalidomide attenuates bone cancer pain and decreases spinal tumor necrosis factor-alpha expression in a mouse model","volume":"6","author":"Gu","year":"2010","journal-title":"Mol. Pain"},{"key":"10.1016\/j.intimp.2015.08.037_bb0120","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ejpain.2008.09.008","article-title":"Differential analgesic effects of morphine and gabapentin on behavioural measures of pain and disability in a model of osteoarthritis pain in rats","volume":"13","author":"Vonsy","year":"2009","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.intimp.2015.08.037_bb0125","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1084\/jem.136.6.1329","article-title":"Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2. A new model for the hypercalcemia of cancer","volume":"136","author":"Tashjian","year":"1972","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2015.08.037_bb0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm1519","article-title":"NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF","volume":"13","author":"Park","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2015.08.037_bb0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0006-8993(94)91566-0","article-title":"Characterization of cytokine-induced hyperalgesia","volume":"654","author":"Watkins","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2015.08.037_bb0140","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/74999","article-title":"Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord","volume":"6","author":"Honore","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2015.08.037_bb0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1615\/CritRevEukarGeneExpr.v10.i2.50","article-title":"Molecular mechanisms of tumor\u2013bone interactions in osteolytic metastases","volume":"10","author":"Chirgwin","year":"2000","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.intimp.2015.08.037_bb0150","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neulet.2003.12.007","article-title":"Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia","volume":"361","author":"Sommer","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.intimp.2015.08.037_bb0155","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1523\/JNEUROSCI.23-07-02517.2003","article-title":"Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons","volume":"23","author":"Schafers","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2015.08.037_bb0160","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1523\/JNEUROSCI.3338-07.2008","article-title":"Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord","volume":"28","author":"Kawasaki","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2015.08.037_bb0165","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1073\/pnas.0409225102","article-title":"A cascade of cytokines mediates mechanical inflammatory hypernociception in mice","volume":"102","author":"Cunha","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2015.08.037_bb0170","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1529-8027.2001.01010.x","article-title":"Etanercept reduces hyperalgesia in experimental painful neuropathy","volume":"6","author":"Sommer","year":"2001","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.intimp.2015.08.037_bb0175","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/exnr.1998.6797","article-title":"Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1","volume":"151","author":"Sommer","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2015.08.037_bb0180","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/BRS.0b013e318162340a","article-title":"Effect of etanercept, a tumor necrosis factor-alpha inhibitor, on neuropathic pain in the rat chronic constriction injury model","volume":"33","author":"Zanella","year":"2008","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.intimp.2015.08.037_bb0185","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1529-8027.2011.00362.x","article-title":"The ology of neuropathy: an integrative review of the role of neuroinflammation and TNF-alpha axonal transport in neuropathic pain","volume":"16","author":"Myers","year":"2011","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.intimp.2015.08.037_bb0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-2094-7-27","article-title":"TNF-alpha and neuropathic pain\u2014a review","volume":"7","author":"Leung","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2015.08.037_bb0195","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1073\/pnas.1011774108","article-title":"Blockade of TNF-alpha rapidly inhibits pain responses in the central nervous system","volume":"108","author":"Hess","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2015.08.037_bb0200","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.nutres.2009.06.008","article-title":"Green tea and bone metabolism","volume":"29","author":"Shen","year":"2009","journal-title":"Nutr. Res."},{"key":"10.1016\/j.intimp.2015.08.037_bb0205","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/ajcn\/86.4.1243","article-title":"Tea drinking is associated with benefits on bone density in older women","volume":"86","author":"Devine","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.intimp.2015.08.037_bb0210","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/jbmr.5650101125","article-title":"Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study","volume":"10","author":"Johnell","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.intimp.2015.08.037_bb0215","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainresbull.2014.12.004","article-title":"Nociceptive spinal cord neurons of laminae I\u2013III exhibit oxidative stress damage during diabetic neuropathy which is prevented by early antioxidant treatment with epigallocatechin-gallate (EGCG)","volume":"110","author":"Raposo","year":"2015","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.intimp.2015.08.037_bb0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2011.12.070","article-title":"Role of neuronal nitric oxide synthase in the antiallodynic effects of intrathecal EGCG in a neuropathic pain rat model","volume":"510","author":"Choi","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.intimp.2015.08.037_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2008.07.053","article-title":"Effects of EGCG on voltage-gated sodium channels in primary cultures of rat hippocampal CA1 neurons","volume":"252","author":"Deng","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.intimp.2015.08.037_bb0230","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1177\/1933719113518984","article-title":"Possible loss of GABAergic inhibition in mice with induced adenomyosis and treatment with epigallocatechin-3-gallate attenuates the loss with improved hyperalgesia","volume":"21","author":"Chen","year":"2014","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.intimp.2015.08.037_bb0235","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.archoralbio.2014.02.011","article-title":"The effect of epigallocatechin-3-gallate (EGCG) on human alveolar bone cells both in vitro and in vivo","volume":"59","author":"Mah","year":"2014","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.intimp.2015.08.037_bb0240","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s11064-013-0976-5","article-title":"Intrathecal epigallocatechin gallate treatment improves functional recovery after spinal cord injury by upregulating the expression of BDNF and GDNF","volume":"38","author":"Tian","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.intimp.2015.08.037_bb0245","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00702-011-0764-9","article-title":"(\u2212)-Epigallocatechin-3-gallate increases the number of neural stem cells around the damaged area after rat traumatic brain injury","volume":"119","author":"Itoh","year":"2012","journal-title":"J. Neural Transm."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915300928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915300928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T11:44:30Z","timestamp":1567165470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576915300928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1567576915300928"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2015.08.037","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigallocatechin-3-gallate attenuates bone cancer pain involving decreasing spinal Tumor Necrosis Factor-\u03b1 expression in a mouse model","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2015.08.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}